Abstract

Objective To evaluate the role of serum immunoglobulin G4 (IgG4) in differentiating autoimmune pancreatitis (AIP) from pancreatic cancer(PC). Methods The database, including Medline, EMBASE, Science Direct, Springer link, CBM, Wanfang , VIP and Cnki were searched by computer and the publication date was before April 1, 2015. The studies on evaluating the accuracy of IgG4 in differentiating AIP from PC were screened and selected according to strict determined inclusion and exclusion criteria. Quality assessment was made by QUADAS scale. The publication bias were assessed by Stata12.0 software . The heterogeneity of included articles, calculate the pooled sensitivity, specificity, positive likelihood, negative likelihood were anylyzed by Meta-Disc1.4 software, respectively, and draw the summary ROC (SROC) curve. Results A total of 13 English articles were included and 1 403 patients were involved. The pooled sensitivity was 74% (95% CI 70%~78%), the pooled specificity was 93% (95% CI 91%~95%), the positive likelihood ratio was 10.74 (95% CI 7.16~16.11), the negative likelihood ratio was 0.25(95% CI 0.17~0.35) and the area under SROC curve was 0.9340. Conclusions IgG4 has high diagnostic efficacy but low misdiagnosis rate in differentiating AIP from PC, which can be used as one of early diagnostic markers for AIP. Key words: Pancreatitis; Autoimmune diseases; Immunoglobulin G4; Diagnosis differential; Meta-analysis

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.